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ABSTRACT
Introduction: Symptomatic hip osteoarthritis (OA) is a
disabling condition with up to a 25% cumulative
lifetime risk. Total hip arthroplasty (THA) is effective in
relieving patients’ symptoms and improving function. It
is, however, associated with substantial risk of
complications, pain and major functional limitation
before patients can return to full function. In contrast,
hip arthroscopy (HA) is less invasive and can postpone
THA. However, there is no evidence regarding the delay
in the need for THA that patients would find acceptable
to undergoing HA. Knowing patients’ values and
preferences (VP) on this expected delay is critical when
making recommendations regarding the advisability of
HA. Furthermore, little is known on the optimal amount
of information regarding interventions and outcomes
needed to present in order to optimally elicit patients’ VP.
Methods and analysis: We will perform a
multinational, structured interview-based survey of
preference in delay time for THA among patients with
non-advanced OA who failed to respond to conservative
therapy. We will combine these interviews with a
randomised trial addressing the optimal amount of
information regarding the interventions and outcomes
required to elicit preferences. Eligible patients will be
randomly assigned (1 : 1) to either a short or a long
format of health scenarios of THA and HA. We will
determine each patient’s VP using a trade-off and
anticipated regret exercises. Our primary outcomes for
the combined surveys will be: (1) the minimal delay time
in the need for THA surgery that patients would find
acceptable to undertaking HA, (2) patients’ satisfaction
with the amount of information provided in the health
scenarios used to elicit their VPs.
Ethics and dissemination: The protocol has been
approved by the Hamilton Integrated Research Ethics
Board (HIREB13-506). We will disseminate our study
findings through peer-reviewed publications and
conference presentations, and make them available to
guideline makers issuing recommendations addressing
HA and THA.
BACKGROUND
Osteoarthritis and surgical options
Osteoarthritis
Osteoarthritis (OA) is the most common form
of chronic arthritis. Approximately 15% of
men and women suffer from symptomatic
OA,1 representing a large burden on patients,
the healthcare system and society.
Symptomatic hip OA is a particularly disabling
condition with a cumulative lifetime risk of up
to 25%. Conservative management of hip OA
includes exercise, weight reduction, physical
therapy and medications focusing on relieving
symptoms, improving joint function and opti-
mising the quality of life.2 Pharmacological
and non-pharmacological interventions for
severe OA are, however, substantially less effect-
ive than surgical treatment.3 Consequently,
most patients with severe hip OA eventually
need total hip arthroplasty (THA).3
Total hip arthroplasty
With an ageing population increasingly inter-
ested in staying physically active,4 the fre-
quency and cost of THA continues to grow.
Currently, more than a half million THA pro-
cedures are performed annually in the UK
and USA alone, and in 2010 the global
market was estimated to be as high as US$4.7
billion. 5
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After the failure of conservative treatment, THA is
usually effective in relieving patients’ symptoms and
improving function, with more than 95% prosthesis sur-
vivorship at 10-year follow-up and more than 80% sur-
vivorship at 25-year follow-up.6 7 However, THA is also a
major procedure, associated with a substantial risk of
complications, and with weeks of pain and major func-
tional limitations before patients can return to full func-
tion. Therefore, patients and caregivers are interested in
less invasive interventions that could postpone THA.
Hip arthroscopy
Less invasive interventions include arthroscopy, partial
replacements and bone-preserving techniques. They have
shown varying success rates among patients with OA.8 Hip
arthroscopy (HA) is a new and also the fastest growing pro-
cedure within orthopaedic surgery. 8 Despite the lack of
high-quality evidence, the number of HAs performed is
expected to double in the USA in 2013 compared with
2011.9 HA is used to treat intra-articular pathology of the
hip, including mild hip OA. Compared with THA, it has
the advantages of being minimally invasive and having
fewer complications.10 Compared with THA, arthroscopy
may help patients achieve a higher level of function more
quickly with, over the short term, less restriction on exer-
cise. The expectation, however, is that patients’ underlying
OA will progress and THA will ultimately become neces-
sary. The question then arises: what delay in the need for
THA would warrant a patient undergoing HA? This is a
question of values and preferences.
Measuring patients values and preferences
There are a number of techniques available for eliciting
patients’ direct choices of which the probabilistic version of
the threshold technique, also called the probability trade-
off exercise, is widely used.11 Following descriptive and
probabilistic information regarding the beneﬁts and harms
associated with treatment choices—for example, treatment
A and B—in which the relative beneﬁts of treatment A
versus B are large, the respondent is asked to choose one
option. Typically, patients will choose treatment A. The
interviewer then presents an alternative situation in which
the relative beneﬁts of A versus B are very small, and
patients typically choose B. The interviewer then presents a
small reduction in the probability of beneﬁts, relative to
the ﬁrst scenario, for option A. If the patient continues to
choose A, the next scenario presents a small increase in
the beneﬁts of A versus B relative to the second scenario.
The process is repeated until the indifference point
between A and B is established (ping-pong approach).12
Utility elicitation uses a very different approach, pre-
senting health states and using one of a variety of techni-
ques to elicit the respondent’s rating of the value of the
health state on a scale between death (typically 0) and
full health (typically 1.0 or 100). The patients’ responses
are used to build a decision model that calculates the
treatment option that, given the patient’s utilities,
achieves the maximum utility-adjusted outcome.13 14
Complementary approaches to assess patients’
decision-making integrate emotional aspects of the
process. One such approach focuses on regret, an aver-
sive emotion people experience when they believe their
current situation would have been better had they acted
differently in the past.15 16 In theory, regret is inﬂuenced
by intuitive, affect-based, and analytical, deliberative pro-
cesses.17 18 Reﬂecting on the anticipated regret of par-
ticular decisions (eg, choosing A vs B in the example
above) may alert people to the choice that would be
most likely to avoid this aversive emotion.19 20 The antici-
pated regret theory-based approach preserves a rational
decision-making framework, while allowing anticipation
of the effect of the decision on emotions.21
Using both (direct choice) trade-off and anticipated
regret exercises, our study will provide empirical evi-
dence regarding the delay in the need for THA that
patients would ﬁnd acceptable to undergoing HA.
Amount of information presented to elicit patients’
values and preferences
The choices patients make are critically dependent on
how the health scenario (HS) that characterises the pro-
cesses and outcomes of the alternative management
options (A and B in the above—THA and HA in the
current project) is presented. Research in marketing has
addressed some of the relevant issues. The information-
processing framework22 suggests that that there are
limits to the human ability to assimilate and process
information, and that once these limits are surpassed,
behaviour becomes confused and dysfunctional.23
Evidence suggests an inverted U-shaped relationship
between information available and decision quality, in
which individuals with too little or too much informa-
tion made poorer decisions than those with an inter-
mediate amount of information.24 25
Other indirect evidence comes from research on
written consent forms.26 27 Individuals often skim over
consent forms for clinical trials in oncology if they are
longer than 1000 words or four pages.28 Twenty-seven
oncology trials showed that patients obtained signiﬁ-
cantly higher objective knowledge when the consent
form page count was seven or less.29
In the area of pharmaceutical product choice, partici-
pants have had a better understanding of shorter and
easier information presentations.25 One might expect,
however, that if the information becomes limited, the
decision quality will deteriorate.
Patients’ values and preferences on OA surgical options
Given the existing evidence, both HA and THA repre-
sent reasonable choices for patients with non-advanced
OA. The choice may, however, be challenging. On the
one hand, HA is likely to achieve only transient improve-
ment in function. On the other hand, the morbidity
associated with THA is substantial.
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Therefore, one of the key aspects in the choice
between HA and THA is the duration of delay in the
need for THA that patients may achieve with HA. If
patients demand a delay time much greater than HA can
realistically achieve, the procedure should seldom be con-
sidered. On the other hand, if patients would be satisﬁed
with a much shorter delay time, the procedure should be
frequently considered. There is currently no empirical
evidence addressing patients’ values and preferences
regarding the delay they would demand to undertake
HA. Knowing typical patients’ values and preferences
regarding this expected delay is likely to be helpful for
patients and healthcare providers in the clinical encoun-
ter and for guideline panellists when making recommen-
dations regarding the advisability of HA.
The assessment of patients’ values and preferences
will be valid only to the extent patients receive sufﬁ-
ciently accurate information on the outcomes of avail-
able treatment options presented in ways that they can
easily process. Thus far, only limited indirect evidence
informs us on the optimal amount of information to
provide in scenarios when eliciting patients’ preferences.
Our study will provide direct empirical evidence on
the optimal amount of information to provide when eli-
citing patients’ values and preferences. It may also
provide insight into the amount of information to
provide in shared decision-making, although our study
only indirectly addresses that issue.
OBJECTIVES
The purpose of this study is to improve the management
of patients with non-advanced symptomatic hip OA who
failed conservative treatment by determining their
values and preferences regarding the choice between
immediate THA versus HA.
In the Pilot stage of our study, we will assess the following
feasibility issues: (1) recruitment rate; (2) length of time
to conduct the interview and ﬁll out all the study mea-
surements; (3) potential personnel and data manage-
ment issues.
In Study 1—our primary objective is to determine the
minimal delay time in the need for THA surgery that
patients would ﬁnd acceptable to undertake HA (which
we will refer to as the ‘delay time’). Secondary objectives
include assessing patients’ anticipated regret if the delay
would differ from their expectations, as well as potential
determinants of their preference (eg, age, gender, edu-
cational level and socioeconomic status).
In Study 2—our objective is to assess the ease of under-
standing, optimal quantity of information and patients’
satisfaction regarding alternative formats of the HSs
used to elicit their preferences.
METHODS
Study design
In a pilot study, we will assess the following feasibility
issues: (1) recruitment rate; (2) length of time to
conduct the interview and ﬁll out all the study measure-
ments; (3) potential personnel and data management
problems in a real-life setting. We will perform this study
at the outpatient orthopaedic clinic of the McMaster
University Medical Center (Hamilton, Ontario, Canada).
Study 1: We will perform a multinational, cross-
sectional, interview-study to assess the delay in THA that
patients would demand to choose HA.
Study 2: Within Study 1, we will conduct a randomised
trial comparing a short version versus a long version of
HA and THA HSs.
Figure 1 shows the study ﬂow.
Setting: The study will take place at McMaster
University Medical Center, Hamilton, Canada; St. Michael’s
Hospital, Toronto, Canada; Hospital de Sant Pau,
Barcelona, Spain; and Sorocaba Hospitals, São Paulo,
Brazil.
Study population
The population of interest consists of adults diagnosed
with non-advanced hip OA. Table 1 presents the detailed
inclusion and exclusion criteria.
Recruitment strategy
We will prospectively identify consecutive patients con-
ﬁrmed with non-advanced hip OA referred for consider-
ation of HA. The orthopaedic surgeon will send a letter
in advance of their visit to inform patients about our
research project and the possibility of being approached
by our research assistant (RA) for this study. The RA will
then make initial contact with all the patients by phone
to explain the purpose of the study. When the patients
come to the orthopaedic clinic, we will ask them for
their written informed consent.
Participants’ interview
Baseline information
We will document patients’ age, gender, ethnicity, educa-
tional level (not completed high school; completed high
school only; some college/university; completed college
or university), yearly income, and their impression of
the experience of close relatives or friends who have
undergone HA or THA (categorised as extremely dissat-
isﬁed; dissatisﬁed; neutral; satisﬁed; extremely satisﬁed,
or differing across individuals).
Health scenarios
The HSs are designed to inform patients of the surgical
options. On the basis of the available evidence,30 we will
include the following ﬁve sections in the HSs for THA
and HA26: (1) brief introduction to the surgery31; (2)
description of the surgical procedure; (3) postoperative
recovery and rehabilitation32; (4) expected beneﬁts; (5)
risks and potential complications (see online supple-
mentary appendix: Script #1: Health scenarios).
The short versions have approximately 850 words and
the long versions approximately twice the number of
words; both versions use the same subheadings.
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To ensure that we present accurate estimates of the
beneﬁts and risks of THA and HA to patients,33 con-
veyed in the most simple and easy-to-understand way
possible, we applied a rigorous process to develop these
HSs.
First, we performed a search on PubMed to retrieve
relevant content from systematic reviews, randomised
control trials (RCT) and observational studies. Evidence
from systematic reviews was preferred if available.
Second, we reviewed THA booklets from the Brant
Community Healthcare System, Hamilton Health
Sciences, Joseph Brant Memorial Hospital, Niagara
Health System, St. Joseph’s Healthcare Hamilton,
National Institute of Arthritis and Musculoskeletal, and
Skin Diseases (NIAMS) to inform SCENARIO design
and content. We also reviewed information from other
sources such as the Informed Medical Decisions
Foundations (IMDF)34 and National Institute of Health
for both THA and HA HSs (when available).
Third, we considered the following strategies to
increase the ease of understanding and readability of
our scenarios.35 We focused the material on key con-
cepts with consistent and simple words aiming for 1–2
syllables.32 36 A clear topic sentence was used at the
beginning of each subheading with the following details
and examples.37 We used a conversational style from the
second person point of view (ie, ‘you’).37 We also used
the Flesch-Kincaid Grade Level test in Microsoft Word
2011 to ensure that the English was understandable for
people with a grade 10 level education.
Finally, we revised our scenarios based on feedback
from 15 orthopaedic surgeons (8 of them commented
on THA, and 7 of them commented on HA); from two
focus groups (3 patients in each group) and four indi-
vidual interviews with a total of 10 patients (5 for each
surgery) who had undergone THA or HA; and ﬁve
physiotherapists.
For the Spanish and Portuguese part of the study, an
experienced medical translator will undertake the initial
translation. In each language, one clinical epidemiolo-
gist and one orthopaedic surgeon, native in the
non-English language and ﬂuent in English, will check
the translation and discuss potential revisions with the
translator. After we obtain the Spanish and Portuguese
versions, back translations will be performed and
checked by the epidemiologist and the orthopaedic
Figure 1 Flow chart of study
design (HS, health scenario).
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surgeon, with further revisions to the Spanish and
Portuguese versions if necessary.
Randomisation of the HSs
Participants will be randomised to receive the short or
long format of the scenarios in coded packages that the
interviewer will open at the start of the interview. We will
perform central randomisation using a computer-gener-
ated randomised system at McMaster University with an
allocation ratio of 1:1 and random blocks size (2,4,8).
We will ask participants to read hard copies of the cor-
responding HSs (short or long). At the end of the inter-
view—that is, after the trade-off exercise, anticipated
regret exercise and a check for consistency and under-
standing that we will describe subsequently—the RA will
show patients in each group the version they have not
yet seen and ask about their preferred format. If partici-
pants have more content questions regarding the scen-
arios, the RA will instruct the patient to ask the
orthopaedic surgeon for further assistance in the
patient–doctor consultation after the interview.
Trade-off exercise
After participants have read the initial HS (short or long
version), we will assess the minimum acceptable delay
(delay time) in THA that patients would ﬁnd acceptable
to undergo HA. We will use the following generic ques-
tions: “By how much longer should the arthroscopy post-
pone the need for hip replacement surgery for you to
consider the hip arthroscopy worthwhile? Would you
choose hip arthroscopy if it would delay the need for
total hip replacement by [delay time in months/year]?”
We will offer a range of delay times, alternating between
short and long times in a ping-pong strategy, for
example, 3 months—12 years—6 months—10 years, etc.
We will progressively narrow the range of the alternatives
offered as we repeat the exercise.
The lower bound of delay time offered (ie,
3 months) is just below the anticipated least stringent
participants’ demand and also corresponds to the
shortest follow-up time in studies that evaluate the efﬁ-
cacy of HA.38 For the upper bound initially offered, the
literature suggests that the most optimistic estimate of
the time by which HA may delay THA is approximately
10 years.39 If patients are not satisﬁed with the upper
boundary of the delay time—that is, they would
demand a delay of more than 12 years before they
would undergo HA—there will be provision for them
to express this preference.
Anticipated regret exercise
Following the trade-off exercise, we will assess partici-
pants’ anticipated regret associated with choosing or not
choosing a treatment alternative. We will measure antici-
pated regret using a 100 mm visual analogue scale (VAS)
called the feeling thermometer,40 anchored at no regret
(0) to maximum regret (100; ﬁgure 2 anticipated regret
VAS).
We will assess anticipated regret at ﬁve different time
points (the patient personal threshold determined
during the trade-off exercise, as well as two shorter and
two longer options). For example, if the patient chose
2 years as their shortest delay time, we would ask her:
“How much regret would you feel about choosing HA if
you need to have a total hip replacement surgery after
12 months/1.5 years/2 years/3 years/4 years?” This
process allows us to check for inconsistent answers (see
below).
Blinding
Since this is a patient educational trial, the interviewers
(data collectors) cannot be blinded. The orthopaedic
surgeons, patients (outcome assessors) and data analysts
will be blinded to the sequence of giving HSs.
Outcomes
Our primary outcome measures for the pilot stage regarding
feasibility issues are the recruitment rate, as well as the
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
(1) Patient is at least 40 years old (1) Patient has a history of prior hip surgery
(2) Patient diagnosed by X-ray or MRI with mild or moderate
(grades 1 and 2) OA based on the Tonnis classification of OA51
Grade 0: no signs of OA
Grade 1: mild: increased sclerosis, slight narrowing of the joint
space, no or slight loss of head sphericity
Grade 2: moderate: small cysts, moderate narrowing of the joint
space, moderate loss of head sphericity
Grade 3: severe: large cysts, severe narrowing of obliteration of
the joint space, severe deformity of the head
(2) Patient is unable to complete the research tasks
due to cognitive impairment or language barriers
(3) Patient has a history of failed conservative management (3) Patient is unwilling or unable to provide informed
consent
(4) Patient provides a written informed consent
OA, osteoarthritis.
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length of time to conduct the interview and ﬁll out all
the outcome measurements. We will explore the poten-
tial personnel and data management problems in the
McMaster Medical Center to ensure the quality of the
deﬁnitive stage of our study. We will note the number of
participants enrolled each week. The mean and SE of
the centre’s recruitment rate over the recruitment
period will be our study recruitment rate. We will also
calculate the percentage of eligible patients who agree
to participate. We will time the length of the interview,
as well as the length of ﬁnishing interviewers’ admini-
strated or patients’ administrated questions.
We will consider recruitment feasible for a large study
if we will be able to recruit two patients at McMaster
Medical Center per week (ie, 100 participants over
50 weeks). We will consider the pilot stage (approxi-
mately 2 months) to be successful, and a large multicen-
tre RCT to be feasible if: (1) we successfully recruit 20%
of the patients according to our estimated sample size in
2 months; (2) we will be able to ﬁnish the interview and
all the outcome assessments in approximately 1 h (see
table 2 for outcomes and corresponding objectives).
We will modify our protocols in response to limitations
with respect to excessive length of the interview, difﬁcul-
ties with comprehension or ambiguities in the questions,
and personnel or data management problems identiﬁed
in the pilot.
For Study 1, our outcomes are:
Primary outcome: the minimal delay in the need for THA
surgery that patients would ﬁnd acceptable to undertake
HA (which we will refer to as the ‘delay time’).
Secondary outcomes:
1. Independent predictors of the primary outcome
include age, gender, educational level, socio-
economic status and family/friends’ experiences with
previous THA and/or HA.
2. Patients’ anticipated regret scores on a 100 mm VAS
at ﬁve different time points (the one patients chose
in the trade-off exercise, and two shorter and two
longer options).
For Study 2, our outcomes are:
Primary outcome: patients’ satisfaction on the scenarios
after reading the initial scenarios. Interviewers will deter-
mine the degree of satisfaction participants place in the
scenarios using a seven-point Likert-type scale with
response options: completely dissatisﬁed, mostly dissatis-
ﬁed, somewhat dissatisﬁed, neither satisﬁed nor dissatis-
ﬁed, somewhat satisﬁed, mostly satisﬁed, completely
satisﬁed.
Secondary outcomes:
1. Ease of understanding: we will assess participants’
impression of understanding of each scenario using a
seven-point Likert-type scale with response options:
extremely hard, very hard, hard, not easy not hard,
easy, very easy, extremely easy.
2. Information quantity: we will ask participants to rate the
quantity of the information displayed in the initial pre-
sented scenario by a seven-point Likert-type scale with
response options: much too little, somewhat too little,
slightly too little, about right amount of information,
slightly too much, somewhat too much, much too much.
3. Patients’ preference on length of format: after
patients ﬁnish reading both the long and short ver-
sions of scenarios, we will ask them about their pref-
erence for the short or long version, using a
seven-point Likert-type scale with response options:
short version much better, short version somewhat
better, short version little better, no preference, long
version little better, long version somewhat better,
long version much better.
Data collection
A trained interviewer will collect all the outcomes by com-
pleting the case-report forms at the end of the interview.
No follow-up and further data collection will be involved.
Sample size calculation
Study 1
Owing to the paucity of similar studies in the literature,
we are unable to estimate the SE of delay time precisely.
If the data are normally distributed, 99.7% of the area
under the normal distribution curve lies within 3 SDs.41
We assume that the range of delay time (12 years) will
be normally distributed. Therefore, we anticipate an SD
of approximately 2 years. We developed the sample size
estimation table using the SD and varying the CI around
the mean to obtain a sample size using the formula
below42 (table 3).
n ¼
4z21a=2s
2
L2
N represents the sample size, σ represents the SE, and L
represents the CI around the mean.
At the end of the pilot stage, we will calculate the SE
of delay time in the 20 patients as a reference point to
modify our earlier sample size estimation for the deﬁnite
study.
Figure 2 Anticipated regret visual analogue scale.
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Table 2 Summary of analysis plan
Study Objectives Outcomes Predictors Hypothesis
Outcome
measure Methods of analysis
Pilot stage
Determine
feasibility
(A) Recruitment rate 2 Participants/week Participants per
week
(B) Time to conduct the
interview and finish all the
measurements
1 h would be optimal Interview duration
(C) Patients’ attrition Less than 5% Patients’ attrition
rate
Study 1:
interview
study
Primary (A) Delay time Age, gender, ethnicity,
educational level, social
economics status and
medical history
Trade-off
exercise
Normally distributed: mean
delay time +SD; mean delay
time and CI
If data are skewed: mode,
median and IQR
Secondary (A) Patients’ anticipated
regret scores
100 mm visual
analogue scale
t test
Study 2:
RCT
Primary (A) Patients’ satisfaction
on the HSs
Higher satisfaction on
the short version
7-point
Likert-type scale
t test
Secondary (A) Understandability Both have rated as 5/7 7-point
Likert-type scale
t test
(B) Information quantity Short will be rated at 4;
long will be rated at 5
7-point
Likert-type scale
t test
(C) Patients’ preference
on the length of format
Prefer the short
version
7-point
Likert-type scale
t test or Mann-Whitney U test
Sensitivity
analyses
Patients’ satisfaction on the
HSs
Higher satisfaction on
the short version
7-point
Likert-type scale
Mann-Whitney U test
Comprehensibility Both have 5/7 7-point
Likert-type scale
Mann-Whitney U test
Information quantity Short will be 4; long
will be 5
7-point
Likert-type scale
Mann-Whitney U test
Patients’ preference
on the length of format
Prefer the short
version
7-point
Likert-type scale
Mann-Whitney U test
HS, health scenario; RCT, randomised controlled trial.
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Study 2
Based on Cohen’s rule of sums,43 we used ‘SD=0.5’ to
calculate the sample size to achieve a medium effect
size. With a sample size of 62 in each group, the trial is
powered to detect a medium effect size of mean=0.5 or
a larger given 80% power level and α=0.05 in a two-sided
test. Considering that the result will be obtained imme-
diately after the assessment and all outcomes will be
interviewer administrated, we anticipate no loss to
follow-up. We also made a sample size estimation table
with different CIs around the mean (table 3). Sample
size calculation is performed using SPSS (Statistical
Package for the Social Sciences) V.21.0 for Windows.
After ﬁnishing the pilot stage of our study, we will
compare the estimated sample size for studies 1 and 2
and take the larger number as our ﬁnal sample size for
the combined studies.
Data analysis and interpretation
Study 1
Description of baseline characteristics
We will present patients’ age, gender, ethnical/cultural
group, educational level, socioeconomic status and
medical history.44 Means and SDs will be used to present
continuous variables and a two-tailed t test (or
Mann-Whitney U test for non-normal distributions) to
detect signiﬁcant differences (p<0.05) between group
means. We will use proportions and frequency tables to
present categorical variables and a two-tailed Fisher’s
Exact test will be used to detect statistically signiﬁcant
(p<0.05) differences between two groups.
Primary and secondary outcome(s)
We will assess the distribution of the mean delay time
and represent it graphically using histogram(s). If the
data are normally distributed, we will present the mean
delay time and SD. We will also estimate 95% CIs of the
mean. If the data are skewed, we will present the mode,
median and IQR.
Multiple variable linear regressions will be undertaken
to determine statistically independent predictors of the
threshold of delay time. In this analysis, the delay time
will be the dependent variable and the independent
variables will be the previous experience of THA and
HA in friends and family, age, gender, socioeconomic
status and educational level.
After presenting the HSs and recording participants’
response with both ‘trade-off’ and anticipated regret
exercise, we will compare results between these two mea-
surements of participants’ values and preferences.
We have deﬁned three possible patterns of inconsist-
ent response (see table 4 Inconsistency checking). If the
participants’ answers fall into any of these patterns, the
interviewers will review the participants’ original answers
without, however, implying that they must modify their
original choices. If participants conﬁrm their original
answers, interviewers will determine and record the
reasons for the participants’ inconsistent choices based
on the participants’ explanation. If patients, following
the review of the relation between their trade-off and
regret choices, desire to modify their chosen delay time,
interviewers will repeat the trade-off exercise.
For the analyses above, we will determine whether the
delay time differs between those with an apparently high
level of understanding and those who demonstrate any
of the inconsistencies depicted in table 4. If we ﬁnd an
important discrepancy between the results of patients
categorised as understanding and not understanding, we
will focus our primary analysis on the group of patients
who apparently have a high level of understanding.
Study 2
Baseline characteristics description
We will summarise patients’ age, gender, ethnical/cul-
tural group, educational level and social economics
status in a table.
Primary and secondary outcome(s)
Our primary outcome will be participants’ satisfaction of
the HSs assessed by a seven-point Likert scale. We will
also visualise it by using histogram(s). We will conduct a
two-sided Student t test will to compare mean satisfac-
tion scores and ease of understanding between the short
and long scenarios. We will also calculate the mean dif-
ference and 95% CIs.
For information quantity, we will present a histogram
depicting the proportion of participants’ choice in each
Table 3 Sample size estimation tables
Study α SD (width of CI, years) Sample size
Study 1 0.05 2 0.5 246
1 62
2 16
Study α β SD Difference Sample size (per arm)
Study 2 0.05 0.8 1 0.5 62
1 16
2 4
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category. We will apply two approaches to analyse infor-
mation quantity at the ﬁrst assessment. First, we will deter-
mine if the distribution between the two groups differs by
greater than chance with a two-sided Student t test (if it
is normally distributed) or a Mann-Whitney U test (if it is
not normally distributed). Second, using a χ2 test, we will
determine if the proportions of participants who choose
‘about the right amount of information’, in comparison
to those who choose other response options, differ
between groups.
We will use two approaches to compare participants’ pre-
ferences for the short versus long formats after showing
patients both scenarios. First, we will treat the outcomes on
the seven-point scale as multinomial ordered outcomes.
We will analyse the result using the Mann-Whitney U test.
Second, we will use a more conservative approach and
compare the proportions of participants who prefer the
short format to the proportion of participants who have
either no preference or prefer the long format by using a
χ2 test (table 2: Summary of analysis plan).
ETHICAL AND DISSEMINATION
This study will be performed in accordance with estab-
lished guidelines for research involving human
patients. The proposed study does not pose any safety
risks to participating patients. The research objectives
and study intervention will be explained to the patient
verbally and in writing in easily comprehensible lan-
guage. Written informed consent will be obtained from
all patients. Patients will be informed of their right to
ask for further information at any time and to withdraw
from the study without prejudice to their future care.
In the unlikely event that participants ﬁnd considering
the above scenarios upsetting, the interview will be
immediately stopped and support offered. We will
ensure conﬁdentiality of patient data by anonymising
patients by a unique numerical identiﬁer. Records will
be stored in a secure database. Access to the database
will be restricted to those directly involved in the
design, implementation and analysis of the data. No
patient will be identiﬁable in any publication arising
from the study.
The reporting of Study 1 will conform to the
STROBE statement,45 and that of Study 2 to the
CONSORT statement.46 We will disseminate our study
ﬁndings widely through peer-reviewed publications and
conference presentations, and make them available to
guideline makers issuing recommendations on HA
and THA.
DISCUSSION
Strengths and weaknesses
The design of our study has several strengths. First, we
have incorporated the anticipated regret model as a new
Table 4 Inconsistency checking
Definitions/criteria of inconsistencies Explanations and examples
(1) Participants anticipate that the regret score is higher when
delay in need for THA is longer than it is at their threshold of
delay time
In the example we give that measures anticipated regret
scores: we set the 5 time points as A (12 months), B
(1.5 years), C (2 years), D (3 years) and E (4 years). The
participant chose 2 years as the shortest delay time at which
he/she can accept for processing HA. Then they placed
scores 60 to represent their regret on VAS at 12 months but
scores 90 to represent his/her regret at 1.5 years. In other
words, the regret scores ‘r’ on VAS show: rA<rB OR rB<rC
OR rC<rD OR rD<rE
(2) Participants anticipate substantial regret, although HA
would delay THA longer than their threshold of delay time
We define substantial as the anticipated regret score on VAS
at the time point that they chose in the ‘trade-off’ exercise, or
any longer delay time point is bigger than (30) on the 100
VAS scale
The participant chose 2 years as the shortest delay time at
which they can accept for processing HA. Then they still
placed scores 60 to represent their regret on VAS at 2, 3 or
4 years In other words, the regret scores ‘r’ on VAS show:
rC>0 OR rD>0 OR rE>0
(iii) Patients do not anticipate any regret when delay in THA
ends up being shorter than what their threshold of delay time
Compared to the time point that participants chose in the
‘trade-off’ exercise, the anticipated regret score on VAS at
any shorter delay time point is equal to (0)
For example, the participant chose 2 years as the shortest
delay time at which they can accept for processing HA.
Then they place scores 0 to represent their regret on VAS at
12 months and 1.5 years In other words, the regret scores ‘r’
on VAS show: rA=0 OR rB=0
HA, hip arthroscopy; THA, total hip arthroplasty; VAS, visual analogue scale.
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method in the exploration of patients’ values and prefer-
ences. Based on considerable previously published the-
oretical works by members of our research team,47 48
our study will be the ﬁrst to evaluate and compare its
results with other methodologies. The comparison will
include differences in decisions, inconsistencies and
understanding.
Second, in developing HSs, we obtained input from
patients who have undergone both total hip replace-
ment and HA and from surgeons who have expertise
on total hip replacement and HA. These processes
ensured the accuracy of our HSs that will be used in
the study.
Third, we will be the ﬁrst to explore the association
between inﬂuence from family and friends’ previous
experience on patients’ values and preferences on the
minimal delay time in the need for THA surgery that
patients would ﬁnd acceptable to undertake HA.
Indirect evidence suggests that friends or family
members’ medical advice may inﬂuence patients’ prefer-
ence on medical decisions.49 Men, African-American
men in particular, are more inclined to discuss their
medication concerns and to seek medical advice from
trusted friends more frequently than women.50 Women
are more often inclined to solicit medical advice from
their family members. Identifying the factors that may
inﬂuence patients’ preferences could provide valuable
explanations for the variation on patients’ values and
preferences in future research. Knowing patients’ previ-
ous perception on certain treatment options can help
clinicians to explain certain things more clearly and
makes clinical consultation more efﬁcient.
Fourth, we will check for consistencies in the minimal
delay patients with HA ﬁnd THA surgery acceptable. If
participants have discrepant answers between the trade-
off and anticipated regret exercise, we will provide them
the opportunity to change their responses. Interviewers
will test patients’ understanding of the information pre-
sented using standardised questions and rate respon-
dents’ understanding based on their judgement. This
ensures the validity of patients’ values and preference
elicitation.
Our study plan also has limitations. There are concep-
tual limitations to the anticipated regret exercise. For
instance, no one has studied the relationship between
anticipated regret and actual regret subsequently experi-
enced. If we ﬁnd important discrepancies between
anticipated regret and the trade-off exercise, the inter-
pretation may be challenging; in particular, it may
remain uncertain which method better represents
patients’ real preference. Subsequent studies may be
needed to address such questions arising from our
results.
Implications
Although there is increasing awareness regarding shared
decision-making and patient centred care, the explicit
consideration of values and preferences in the care of
individual patients and in the recommendations made
by clinical practice guidelines remains limited.31–36
Given the existing evidence, the choice between HA
and THA for patients with non-advanced OA is challen-
ging. The research outlined in this protocol will provide
explicit, quantitative expressions of patients’ valuations of
their expected delay of HA on THA. This information
will alert clinicians to this issue and may provide guidance
in their interactions with patients. It will certainly provide
crucial information for guideline developers making
recommendations for clinical practice. Identifying the
factors that may inﬂuence patients’ preferences could
provide insight into variations in the broader perspective
of patients’ values and preferences in future research.
Our protocol also addresses some of the limitations of
the previous studies in the ﬁeld of written medical infor-
mation regarding using an adequate amount of informa-
tion in patients’ values and preference assessment.
Results will have implications for clinical practice in
terms of providing patients with the right amount of
information in the shared decision-making process.
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